<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The myelodysplastic/<z:mpath ids='MPATH_512'>myeloproliferative diseases</z:mpath> (<z:e sem="disease" ids="C1301355" disease_type="Neoplastic Process" abbrv="">MDS/MPDs</z:e>) are a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of myeloid <z:hpo ids='HP_0002664'>neoplasms</z:hpo> that share characteristics with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_512'>myeloproliferative diseases</z:mpath> and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The broad spectrum of clinical manifestations makes <z:e sem="disease" ids="C1301355" disease_type="Neoplastic Process" abbrv="">MDS/MPDs</z:e> extremely difficult to diagnose and treat, with a median survival time of 1-5 years </plain></SENT>
<SENT sid="2" pm="."><plain>No <z:e sem="disease" ids="C0037176" disease_type="Disease or Syndrome" abbrv="">single gene defect</z:e> has been firmly associated with <z:e sem="disease" ids="C1301355" disease_type="Neoplastic Process" abbrv="">MDS/MPDs</z:e>, and no animal models have been developed for these diseases </plain></SENT>
<SENT sid="3" pm="."><plain>The association of deletions on chromosome 20q with <z:e sem="disease" ids="C0027022" disease_type="Neoplastic Process" abbrv="MPD">myeloid malignancies</z:e> suggests the presence of unidentified <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes in this region </plain></SENT>
<SENT sid="4" pm="."><plain>Here we show that the recently identified <z:hpo ids='HP_0011420'>death</z:hpo> inducer-obliterator (<z:chebi fb="47" ids="28014">Dido</z:chebi>) gene gives rise to at least 3 polypeptides (Dido1, Dido2, and Dido3) through alternative splicing, and we map the human gene to the long arm of chromosome 20 </plain></SENT>
<SENT sid="5" pm="."><plain>We found that targeting of murine <z:chebi fb="47" ids="28014">Dido</z:chebi> caused a transplantable disease whose symptoms and signs suggested <z:e sem="disease" ids="C1301355" disease_type="Neoplastic Process" abbrv="">MDS/MPDs</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, 100% of human <z:e sem="disease" ids="C1301355" disease_type="Neoplastic Process" abbrv="">MDS/MPD</z:e> patients analyzed showed <z:chebi fb="47" ids="28014">Dido</z:chebi> expression abnormalities, which we also found in other myeloid but not lymphoid <z:hpo ids='HP_0002664'>neoplasms</z:hpo> or in healthy donors </plain></SENT>
<SENT sid="7" pm="."><plain>Our findings suggest that <z:chebi fb="47" ids="28014">Dido</z:chebi> might be one of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes at chromosome 20q and that the <z:chebi fb="47" ids="28014">Dido</z:chebi>-targeted mouse may be a suitable model for studying <z:e sem="disease" ids="C1301355" disease_type="Neoplastic Process" abbrv="">MDS/MPD</z:e> diseases and testing new approaches to their diagnosis and treatment </plain></SENT>
</text></document>